TGM2 regulated by transcription factor NR3C1 drives p38 MAPK-mediated tumor progression and immune evasion in lung squamous cell carcinoma.

Front Immunol · 2025 · PMC12488625 · PMID 41050683

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

did not reach statistical significanceP = 0.075so close (0.05 < p ≤ 0.1)

Although survival analysis did not reach statistical significance, there was a trend suggesting poorer prognosis for patients with LUSC exhibiting high NR3C1 expression (P = 0.075; Figure 7E ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.